1.2Impact Factor
45 daysTime to First Decision

Thalassemia Reports is published by MDPI from Volume 12 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Thalassemia Reports, Volume 11, Issue 1

March 2021 - 3 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (3)

Select all

Article

2 Citations

2,675 Views

5 Pages

Iron Chelation Therapy Needed for Serum Ferritin Overloaded Patients of Beta Thalassemia Major

Wasim Muhammad,
Muhammad Ishaq,
Muhammad J. Khan,
Umair Ahmad and
Muhammad Waseem

Thalass. Rep.2021, 11(1), 9779;https://doi.org/10.4081/thal.2021.9779

18 June 2021

The main objective of the current study is to evaluate the level and overload of serum ferritin in multi-transfused beta Thalassemia major patients. There is an earnest need to defend the chelation treatment and to make mindfulness about the results...

Full Article

Article

7 Citations

2,770 Views

9 Pages

Hemoglobin Disorders in Europe: A Systematic Effort of Identifying and Addressing Unmet Needs and Challenges by the Thalassemia International Federation

Michael Angastiniotis,
Lily Cannon,
Eleni Antoniou,
Angelo Loris Brunetta,
George Constantinou,
Eva Maria Knoll,
Dimitris Loukopoulos,
Anton Skafi and
Androulla Eleftheriou

Thalass. Rep.2021, 11(1), 9803;https://doi.org/10.4081/thal.2021.9803

17 June 2021

Hemoglobin disorders (thalassemia and sickle cell disease) are a group of hereditary anemias that today occur across the world. The recent population movement has led to a steady increase of carriers and patients in all countries of the European Unio...

Full Article

Article

1,645 Views

7 Pages

Iranian Patients’ Attitudes to Current and Novel Therapies: A Patient Directed Survey

Mahmoud Hadipour Dehshal,
Michael Angastiniotis,
Sachiko Hosoya,
Fatemeh Hashemi Bahremani,
Mehdi Tabrizi Namini and
Androulla Eleftheriou

Thalass. Rep.2021, 11(1), 9514;https://doi.org/10.4081/thal.2021.9514

17 March 2021

Thalassemia is one of the important challenges of the health system in Iran. Recently the medicinal drug of luspatercept and gene therapy have opened new horizons for thalassemia treatment. The present article aims to evaluate the attitude of thalass...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Thalass. Rep. - ISSN 2039-4365

Imprint

Download Flyer